A real-world characterization of a population with eosinophilic esophagitis: looking for severity biomarkers

被引:0
|
作者
Caldeira, Leonor esteves [1 ]
Limao, Rita [1 ]
Bras, Rita [1 ]
Pedro, Elisa [1 ]
Costa, Celia [1 ,2 ]
机构
[1] Ctr Hosp Univ Lisboa Norte EPE, Hosp Santa Maria, Dept Immunoallergol, Lisbon, Portugal
[2] Univ Clin Immunoallergol, Med Fac Lisbon, Lisbon, Portugal
关键词
Atopy; eosinophilic esophagitis; food allergy; sensitization; severity biomarkers; HISTOLOGIC REMISSION; GUIDELINES; MANAGEMENT; DIAGNOSIS; EFFICACY; CHILDREN;
D O I
10.23822/EurAnnACI.1764-1489.292
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background. Eosinophilic esophagitis (EoE) is an immune-mediated chronic esophageal disease, with frequent association with atopy. A vali- dated non/minimally invasive biomarker of disease severity has not been identified. We aimed to determine if sensitization to airborne , food allergens correlates with disease severity , to evaluate the association between clinical and laboratory characteristics with the severity of EoE. Methods. Retrospective study of EoE patients observed in a differentiated center, 2009-2021. The association between patients' diagnosis age, disease duration before diagnosis, sensitization to airborne/food allergens, serum total IgE and peripheral blood eosinophil values and severe clinical disease (presence of symptoms with a significant impact on quality of life and/or >= 1 hospital admission due to EoE complications, namely severe dysphagia, food impaction or esophageal perforation) and histological severe disease (>= 55 eos/hpf and/or microabscesses in esophageal biopsies) was evaluated. Results. 92 patients were observed, 83% male, 87% atopic. There was a mean delay in diagnosis of 4 years (range 0-31). 84% had aeroallergen sensitization and 71% food sensitization. Food impaction and dysphagia were the most frequent symptoms, and severe clinical disease was observed in 55%. Histologically, 37% had severity criteria. Patients with severe clinical disease had a significantly longer mean disease duration before diagnosis than patients without severe clinical disease (79 vs 15 months; p = 0.021). Patients who described food impaction were significantly older at time of diagnosis than those who have never had impaction (18 vs 9 years; p < 0.001). There was no significant association (p < 0.05) between sensitization, serum total IgE and peripheral blood eosinophil values and clinical or histological severity. Conclusions. An older age at diagnosis and a longer disease duration before diagnosis appear to be useful for pre- dicting EoE clinical severity. Despite having been demonstrated a high prevalence of allergic disease, the presence of sensitization to airborne and/ or food allergens do not seem to be useful for predicting clinical or histo- logical severity.
引用
收藏
页码:252 / 262
页数:11
相关论文
共 50 条
  • [41] MitraClip Real-World Data: What Is Missing and Looking Into the Future
    Mesana, Thierry G.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2020, 21 (09) : 1063 - 1064
  • [42] A comparison of different symptomatic reflux esophagitis treatments: A real-world study
    Di Mario, Francesco
    Crafa, Pellegrino
    Franzoni, Lorella
    Tursi, Antonio
    Brandimarte, Giovanni
    Russo, Michele
    Rodriguez-Castro, Kryssia Isabel
    Franceschi, Marilisa
    De Bortoli, Nicola
    Savarino, Edoardo
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 32 (09): : 1075 - 1080
  • [43] Adding value to real-world data: the role of biomarkers
    Plant, Darren
    Barton, Anne
    RHEUMATOLOGY, 2020, 59 (01) : 31 - 38
  • [44] Effect of sacubitril/valsartan therapy on risk stratification biomarkers in a real-world heart failure population
    Barrett, M. J.
    Hammond, M.
    Zhou, S.
    Hanlon, R. O.
    Campbell, P.
    Mcdonald, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 585 - 586
  • [45] REAL-WORLD EVIDENCE OF THE EFFECTIVENESS AND SAFETY OF ORODISPERSIBLE BUDESONIDE TABLET FOR THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS: A MULTICENTRE PROSPECTIVE STUDY EVALUATING THE INDUCTION PERIOD
    Maniero, Daria
    Giorgini, Giorgia
    Ghisa, Matteo
    Lorenzon, Greta
    Bendia, Emanuele
    Coletta, Marina
    Penagini, Roberto
    Vespa, Edoardo
    Barchi, Alberto
    Mari, Amir
    De Bortoli, Nicola
    Visaggi, Pierfrancesco
    Dilaghi, Emanuele
    Annibale, Bruno
    Iovino, Paola
    Caminati, Marco
    Salvatore, Russo
    Savarino, Edoardo V.
    GASTROENTEROLOGY, 2024, 166 (05) : S421 - S422
  • [46] A Real World Study of Cumulative Steroid Burden in Patients With Newly Diagnosed Eosinophilic Esophagitis
    Naeger, Sarah
    Pela, Tiffany
    Radwan, Amr
    Jacob-Nara, Juby
    Nag, Arpita
    Thomas, Ryan
    Tilton, Sarette T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S337 - S337
  • [47] Population Pharmacokinetics of Palbociclib in a Real-World Situation
    Royer, Bernard
    Kaderbhai, Coureche
    Fumet, Jean-David
    Hennequin, Audrey
    Desmoulins, Isabelle
    Ladoire, Sylvain
    Ayati, Siavoshe
    Mayeur, Didier
    Ilie, Sivia
    Schmitt, Antonin
    PHARMACEUTICALS, 2021, 14 (03) : 1 - 14
  • [48] Population Pharmacokinetics of Rivaroxaban in Real-World Patients
    Alqahtani, Saeed
    Alnahdi, Jamilah
    Almofada, Razan
    bin Hazza, Asma'a
    Alsultan, Abdullah
    Alqahtani, Farjah
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (08): : 943 - 949
  • [49] Prescription of sacubitril/valsartan in a real-world population
    Joao Pedro Ribeiro Agostinho, J. R.
    Rodrigues, T.
    Santos, R.
    Cunha, N.
    Rigueira, J.
    Nunes-Ferreira, A.
    Aguiar-Ricardo, I.
    Goncalves, I.
    Guimaraes, T.
    Longo, S.
    Veiga, F.
    Ribeiro, M.
    Lousada, N.
    Pinto, F. J.
    Brito, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 228 - 228
  • [50] The effectiveness of fingolimod in a Portuguese real-world population
    Correia, I.
    Batista, S.
    Marques, I. B.
    Sousa, M.
    Ferreira, R.
    Nunes, C.
    Macario, M. C.
    Sousa, L.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 6 : 41 - 48